Back
Reserves Verdict on 's Plea Against 's Ads Calling Surf Excel Harmful
The has reserved its judgment on an application filed by ) against , the company behind the eco-friendly cleaning brand . The dispute centers on 's advertising campaign that explicitly claims ’s detergent brands Surf Excel and Vim contain chemicals that cause skin irritation and allergies. Justice Anup Jairam Bhambhani heard detailed arguments from both sides and concluded the hearing, reserving an order on whether to grant pending the .
The Core Dispute: or ?
moved the court alleging that ’s advertisements cross the line from permissible into . The ads in question highlight two chemicals—LAS and BIT—which uses in its detergents, and assert that these substances cause skin irritation and allergic reactions. The campaign then urges consumers to switch to ’s allegedly safer alternatives.
, representing , argued that while a manufacturer may claim its own product is superior, the law does not allow a competitor to directly denigrate a rival’s product as harmful or dangerous. He contended that ’s statements are not mere but factual assertions that the finished products of Surf Excel and Vim cause skin irritation—a claim he said is unsupported by any testing on the actual marketed goods.
’s Three-Pronged Defence
’s legal team advanced three principal arguments to resist the . First, they asserted that is a form of protected under . Second, they maintained that truth is a complete defence to a claim of , and ’s statements are truthful. Third, they argued that since the veracity of the claims can only be fully tested at trial, no should be granted unless the defence of truth is “.”
The company submitted a written note elaborating these points, which was taken on record by the court.
Rebuttal: The Limits of
In reply, Senior Advocate Sibal accepted the narrow proposition that truth must ultimately be adjudicated at trial. However, he strongly contested the other two limbs of ’s defence. He submitted that the for evaporates the moment the advertisement becomes deceptive, unfair, misleading, or untruthful. Citing precedents, he argued that an advertisement that goes beyond comparing features and instead makes a direct, unverified attack on a rival product’s safety loses its immunity.
Sibal emphasised that ’s campaign does not merely inform consumers about the presence of certain ingredients common in many detergents. Instead, it explicitly warns that using Surf Excel and Vim will cause skin irritation and allergies—an assertion he described as both scientifically unverified and commercially reckless. He pointed out that no tests on the finished formulations of ’s products have been produced by to substantiate the sweeping claim of harm.
The Legal Framework for Interim Injunctions in Cases
The court’s decision will turn on the well-established principles governing interim injunctions in trademark and matters. In Indian law, a plaintiff seeking an must establish a , , and . For claims, the courts have consistently held that an advertisement that falsely denigrates a competitor’s product—especially by making specific allegations of danger or harm—can be restrained even at an interim stage if the defence of truth appears weak.
The has previously laid down guidelines distinguishing “” from “”: stating one’s own product is better is permissible; stating that a rival’s product is dangerous is not, unless the claim is demonstrably true. ’s reliance on the will likely face scrutiny because the company has not yet produced evidence that the finished products of Surf Excel or Vim cause skin irritation at the concentrations and conditions of normal use.
Implications for Advertising Law and Consumer Protection
This case is being closely watched by brand owners, advertisers, and legal practitioners because it tests the boundaries of in the consumer goods sector. A ruling in favour of could set a precedent that companies must exercise greater caution when making safety-related comparisons. Conversely, if ’s defence prevails, it may embolden smaller brands to aggressively challenge incumbents using ingredient-related claims, even before those claims are fully substantiated.
The case also touches on the intersection of under Article 19(1)(a) and the need to prevent misleading advertisements under the . The court’s will likely influence how truth is assessed at the preliminary stage—whether a mere assertion of truth is enough to defeat an injunction, or whether the defendant must present at least some to support its allegations.
Awaiting the Verdict
With submissions concluded and a written note from already on record, Justice Bhambhani has reserved judgment on ’s application for an . The order is expected in due course and will be keenly awaited by the legal and commercial community. For now, ’s advertisements remain in the market, but the court’s eventual ruling could compel a swift withdrawal or modification of the campaign if succeeds in establishing a strong of .
This case serves as a reminder that aggressive , especially when it implicates consumer health, carries significant legal risks. The ’s decision will help clarify the standard that must be met before a defendant can rely on the to resist an in a suit.
